Blood Clotting articles & resources on Made-in-China.com

Increased Risk of Having a Stroke or Other Blood-Clotting Problem Might Continue Longer

Feb 28, 2014

THURSDAY Feb. 13, 2014, 2014 -- The increased risk of having a stroke or other blood-clotting problem might continue longer after a woman gives birth than previously believed, according to a new study. "Historically, six weeks was the ...

Tags: Stroke Risk, the risk of blood clots, venous thromboembolisms

MIT Chemical Engineers Designed Nanoparticle That Can Deliver Snippets of Genetic Material

Feb 26, 2014

Inspired by tiny particles that carry cholesterol through the body, MIT chemical engineers have designed nanoparticles that can deliver snippets of genetic material that turn off disease-causing genes. This approach, known as RNA ...

Tags: RNA, MIT, Gene Silencing, Nanoparticle

Previous Genetic Studies Suggested Several Genetic Variations

Feb 14, 2014

In a study to be presented on Feb. 6 at 2:45 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report that a variant in SERPINE1, a gene involved in inflammation ...

Tags: Blood Clotting

Tretten Has Been Approved by FDA to Treat a Very Rare Blood Clotting Disorder

Dec 25, 2013

Tretten (coagulation factor XIII A-Subunit recombinant) has been approved by the U.S. Food and Drug Administration to treat a very rare blood clotting disorder called congenital Factor XIII A-Subunit deficiency. People with the genetic ...

Tags: Tretten, blood clotting disorder

Ten Transgenic Piglets Have Been Born This Year in Guangdong Province

Dec 25, 2013

Along with red, green is the color of this holiday season. And bright green is showing up in more than just decorations. ?In Guangdong Province in Southern China, ten transgenic piglets have been born this year, six of them since August, ...

Tags: Consumer Electronics, Electronics

Kcentra Helps Restore Blood Coagulation

Dec 18, 2013

CSL Behring has announced that Kcentra (prothrombin complex concentrate [human]) has received the US Food and Drug Administration (FDA) approval for an expanded indication -- urgent reversal of acquired coagulation factor deficiency induced ...

Tags: CSL Behring, Medicine

FDA Extended Its Review of a Marketing Application for Fusion Protein Alprolix

Dec 5, 2013

Biogen Idec announced that the US Food and Drug Administration (FDA) has extended its review of a marketing application for the long-lasting recombinant factor IX Fc fusion protein Alprolix for haemophilia B by three months. The company ...

Tags: Health, Medicine

Cluster of Tennessee Is a Serious But Preventable Bleeding Disorder

Nov 18, 2013

Federal officials identified a cluster of newborns in Tennessee with late vitamin K deficiency bleeding, a serious but preventable bleeding disorder. Preliminary findings of the investigation of the Centers for Disease Control and ...

Tags: CDC, cluster, infant, Tennessee

Novo Nordisk Has Received Biologics Licence Application Approval From FDA

Oct 18, 2013

Danish pharmaceutical firm Novo Nordisk has received biologics licence application (BLA) approval from the US Food and Drug Administration (FDA) for its recombinant coagulation factor VIII, Novoeight. Novoeight is intended for adults and ...

Tags: Novo Nordisk, Drug

Bayer Has Reported a Net Profit of €841m in Q3, up 74.8%

Aug 5, 2013

German pharma and chemical firm Bayer has reported a net profit of €841m for the second quarter of 2013, with an increase of 74.8% compared to €481m during the comparable period earlier year. The increase in profit is primarily ...

Tags: chemical firm, Bayer

Patient Enrolment in Phase III Trial with Fibrocaps Has Been Completed by Profibrix

Apr 5, 2013

Netherland-based ProFibrix has announced the completion of patient enrolment in pivotal Phase III trial with Fibrocaps (FINISH-3). The multicentre, randomised, single-blind study enrolled around 718 surgical patients with mild to moderate ...

Tags: Profibrix, Fibrocaps, Medicine

The European Commission Has Cleared an Oral Anticoagulant, Eliquis

Nov 28, 2012

The European Commission has cleared an oral anticoagulant, Eliquis, developed by Bristol-Myers Squibb (BMS) and Pfizer. Eliquis 5mg, trade name of apixaban in Europe, is indicated as a twice-daily drug for preventing strokes and systemic ...

Tags: BMS-Pfizer Oral Anticoagulant, oral anticoagulant, Eliquis, apixaban

Baxter International Gained Approval for Advate to Treat Hemophilia a in China

Nov 28, 2012

Baxter International has gained approval for ADVATE [Recombinant Human Coagulation Factor VIII for injection] to treat hemophilia A in China. ADVATE is infused directly into the bloodstream, allowing the body's blood clotting process to ...

Tags: Baxter International, ADVATE, hemophilia A, bleeding episodes

Blood Clotting

Related Products